Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.
about
Development of Liposomal Ciprofloxacin to Treat Lung InfectionsNano-Therapeutics for the Lung: State-of-the-Art and Future PerspectivesClinical experimentation with aerosol antibiotics: current and future methods of administration.Pharmaceutical applications of the Calu-3 lung epithelia cell line.New anti-inflammatory targets for chronic obstructive pulmonary disease.Inhaled antibiotics to treat lung infection.Liposomal antibiotic formulations for targeting the lungs in the treatment of Pseudomonas aeruginosa.Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy.Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives.Antibacterial Activity of Ciprofloxacin-Encapsulated Cockle Shells Calcium Carbonate (Aragonite) Nanoparticles and Its Biocompatability in Macrophage J774A.1.Ciprofloxacin is actively transported across bronchial lung epithelial cells using a Calu-3 air interface cell model.Nanomedical research in Australia and New Zealand.Tuning Ciprofloxacin Release Profiles from Liposomally Encapsulated Nanocrystalline Drug.Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals.Aerosol performance and long-term stability of surfactant-associated liposomal ciprofloxacin formulations with modified encapsulation and release properties.Inhaled simvastatin nanoparticles for inflammatory lung disease.Temperature-sensitive liposomal ciprofloxacin for the treatment of biofilm on infected metal implants using alternating magnetic fields.Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity.Formation of drug nanocrystals under nanoconfinement afforded by liposomes
P2860
Q26764772-9EC1B9C7-DBB5-4692-B768-F23BE1723ED0Q26786162-5DD0FD98-169A-47DB-A462-591FD44AEB94Q30448377-9768B36D-3714-4784-BE39-66EFB20C6EB7Q38111427-652B3538-37B8-4690-8E61-BED6AE35CA83Q38131512-E5D45F2D-38D2-489D-90BF-FD29C69CD7FCQ38162996-43F60C32-9781-44A3-9409-A318325D86F3Q38214155-4F9E6818-F17C-49E3-8FE8-9F69155EC4AAQ38552573-A8275985-41A0-4C79-AE62-971BC9CBF672Q38569772-4F5C35D1-28EC-472A-BE49-5FA3D21B4D91Q38769189-089421DA-468D-42C5-BF49-5E3387379358Q39178955-DFCC28DF-1DF6-4A26-93E4-975CA4B55916Q39307127-28A519E9-FA2E-474F-AC2E-FE7C0D29517DQ41210900-3D134192-755C-40A0-8364-5832343CA718Q41603902-D13DEEA1-2A9D-45AC-8904-35647B116C5DQ41608294-8088020A-4AE4-46F2-A07D-557FDB136729Q47755402-BD487C07-A169-4ACD-A55D-9C6272B7AFDAQ51745320-60FC37AF-4296-48F9-A82D-9058B6864A9CQ52893748-C0C5D6F0-D33D-4782-9626-F0EBAB0476A3Q58493073-F368C5F3-4FA9-4BC6-9560-16253A3DB732
P2860
Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.
@en
Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.
@nl
type
label
Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.
@en
Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.
@nl
prefLabel
Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.
@en
Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.
@nl
P2093
P2860
P50
P1476
Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.
@en
P2093
Helen Agus
Igor Gonda
Paul M Young
P2860
P304
P356
10.1007/S11095-012-0827-0
P577
2012-07-26T00:00:00Z